These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 16005624)

  • 1. Design and syntheses of melanocortin subtype-4 receptor agonists. Part 2: discovery of the dihydropyridazinone motif.
    Ujjainwalla F; Warner D; Snedden C; Grisson RD; Walsh TF; Wyvratt MJ; Kalyani RN; Macneil T; Tang R; Weinberg DH; Van der Ploeg L; Goulet MT
    Bioorg Med Chem Lett; 2005 Sep; 15(18):4023-8. PubMed ID: 16005624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and syntheses of melanocortin subtype-4 receptor agonists: evolution of the pyridazinone archetype.
    Ujjainwalla F; Warner D; Walsh TF; Wyvratt MJ; Zhou C; Yang L; Kalyani RN; MacNeil T; Van der Ploeg LH; Rosenblum CI; Tang R; Vongs A; Weinberg DH; Goulet MT
    Bioorg Med Chem Lett; 2003 Dec; 13(24):4431-5. PubMed ID: 14643340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of a privileged structure leading to potent and selective human melanocortin subtype-4 receptor ligands.
    Bakshi RK; Hong Q; Tang R; Kalyani RN; Macneil T; Weinberg DH; Van der Ploeg LH; Patchett AA; Nargund RP
    Bioorg Med Chem Lett; 2006 Mar; 16(5):1130-3. PubMed ID: 16364639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2-Piperazinecarboxamides as potent and selective melanocortin subtype-4 receptor agonists.
    Palucki BL; Park MK; Nargund RP; Tang R; MacNeil T; Weinberg DH; Vongs A; Rosenblum CI; Doss GA; Miller RR; Stearns RA; Peng Q; Tamvakopoulos C; Van der Ploeg LH; Patchett AA
    Bioorg Med Chem Lett; 2005 Apr; 15(8):1993-6. PubMed ID: 15808454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of potent, selective, and orally bioavailable 3H-spiro[isobenzofuran-1,4'-piperidine] based melanocortin subtype-4 receptor agonists.
    Guo L; Ye Z; Liu J; He S; Bakshi RK; Sebhat IK; Dobbelaar PH; Hong Q; Jian T; Dellureficio JP; Tsou NN; Ball RG; Weinberg DH; MacNeil T; Tang R; Tamvakopoulos C; Peng Q; Chen HY; Chen AS; Martin WJ; MacIntyre DE; Strack AM; Fong TM; Wyvratt MJ; Nargund RP
    Bioorg Med Chem Lett; 2010 Aug; 20(16):4895-900. PubMed ID: 20621473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of potent and selective 1,3,4-trisubstituted-2-oxopiperazine based melanocortin-4 receptor agonists.
    Tian X; Mishra RK; Switzer AG; Hu XE; Kim N; Mazur AW; Ebetino FH; Wos JA; Crossdoersen D; Pinney BB; Farmer JA; Sheldon RJ
    Bioorg Med Chem Lett; 2006 Sep; 16(17):4668-73. PubMed ID: 16766182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melanocortin subtype 4 receptor agonists: structure-activity relationships about the 4-alkyl piperidine core.
    Sebhat IK; Lai Y; Barakat K; Ye Z; Tang R; Kalyani RN; Vongs A; Macneil T; Weinberg DH; Cabello MA; Maroto M; Teran A; Fong TM; Van der Ploeg LH; Patchett AA; Nargund RP
    Bioorg Med Chem Lett; 2007 Oct; 17(20):5720-3. PubMed ID: 17768046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and SAR of potent and orally bioavailable tert-butylpyrrolidine archetype derived melanocortin subtype-4 receptor modulators.
    Guo L; Ye Z; Ujjainwalla F; Sings HL; Sebhat IK; Huber J; Weinberg DH; Tang R; MacNeil T; Tamvakopoulos C; Peng Q; MacIntyre E; van der Ploeg LH; Goulet MT; Wyvratt MJ; Nargund RP
    Bioorg Med Chem Lett; 2008 Jun; 18(11):3242-7. PubMed ID: 18479920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization of privileged structures for selective and potent melanocortin subtype-4 receptor ligands.
    Hong Q; Bakshi RK; Dellureficio J; He S; Ye Z; Dobbelaar PH; Sebhat IK; Guo L; Liu J; Jian T; Tang R; Kalyani RN; Macneil T; Vongs A; Rosenblum CI; Weinberg DH; Peng Q; Tamvakopoulos C; Miller RR; Stearns RA; Cashen D; Martin WJ; Chen AS; Metzger JM; Chen HY; Strack AM; Fong TM; Maclntyre E; Van der Ploeg LH; Wyvratt MJ; Nargund RP
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4483-6. PubMed ID: 20598533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and synthesis of 3-arylpyrrolidine-2-carboxamide derivatives as melanocortin-4 receptor ligands.
    Tran JA; Tucci FC; Arellano M; Jiang W; Chen CW; Marinkovic D; Fleck BA; Wen J; Foster AC; Chen C
    Bioorg Med Chem Lett; 2008 Mar; 18(6):1931-8. PubMed ID: 18294847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of a spiroindane based compound as a potent, selective, orally bioavailable melanocortin subtype-4 receptor agonist.
    He S; Ye Z; Dobbelaar PH; Sebhat IK; Guo L; Liu J; Jian T; Lai Y; Franklin CL; Bakshi RK; Dellureficio JP; Hong Q; Tsou NN; Ball RG; Cashen DE; Martin WJ; Weinberg DH; Macneil T; Tang R; Tamvakopoulos C; Peng Q; Miller RR; Stearns RA; Chen HY; Chen AS; Strack AM; Fong TM; Macintyre DE; Wyvratt MJ; Nargund RP
    Bioorg Med Chem Lett; 2010 Apr; 20(7):2106-10. PubMed ID: 20207541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melanocortin-4 receptor (MC4R) agonists for the treatment of obesity.
    Nargund RP; Strack AM; Fong TM
    J Med Chem; 2006 Jul; 49(14):4035-43. PubMed ID: 16821763
    [No Abstract]   [Full Text] [Related]  

  • 13. Discovery and optimization of pyridazinone non-nucleoside inhibitors of HIV-1 reverse transcriptase.
    Sweeney ZK; Dunn JP; Li Y; Heilek G; Dunten P; Elworthy TR; Han X; Harris SF; Hirschfeld DR; Hogg JH; Huber W; Kaiser AC; Kertesz DJ; Kim W; Mirzadegan T; Roepel MG; Saito YD; Silva TM; Swallow S; Tracy JL; Villasenor A; Vora H; Zhou AS; Klumpp K
    Bioorg Med Chem Lett; 2008 Aug; 18(15):4352-4. PubMed ID: 18632268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1-Amino-1,2,3,4-tetrahydronaphthalene-2-carboxylic acid as a Tic mimetic: application in the synthesis of potent human melanocortin-4 receptor selective agonists.
    Bakshi RK; Hong Q; Olson JT; Ye Z; Sebhat IK; Weinberg DH; MacNeil T; Kalyani RN; Tang R; Martin WJ; Strack A; McGowan E; Tamvakopoulos C; Miller RR; Stearns RA; Tang W; Maclntyre DE; van der Ploeg LH; Patchett AA; Nargund RP
    Bioorg Med Chem Lett; 2005 Jul; 15(14):3430-3. PubMed ID: 15951175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of pyridazinone-based 5-HT(2C) agonists.
    Allerton CM; Andrews MD; Blagg J; Ellis D; Evrard E; Green MP; Liu KK; McMurray G; Ralph M; Sanderson V; Ward R; Watson L
    Bioorg Med Chem Lett; 2009 Oct; 19(19):5791-5. PubMed ID: 19716297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 4,5-dihydropyridazin-3-one derivatives as histamine H₃ receptor inverse agonists.
    Hudkins RL; Aimone LD; Dandu RR; Dunn D; Gruner JA; Huang Z; Josef KA; Lyons JA; Mathiasen JR; Tao M; Zulli AL; Raddatz R
    Bioorg Med Chem Lett; 2012 Jan; 22(1):194-8. PubMed ID: 22142542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of cyclic peptides with agonist activity at melanocortin receptor-4.
    Odagami T; Tsuda Y; Kogami Y; Kouji H; Okada Y
    Bioorg Med Chem Lett; 2006 Jul; 16(14):3723-6. PubMed ID: 16678415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological activity of novel peptide mimetics as melanocortin receptor agonists.
    Liu XW; Ma J; Colson AO; Doersen DC; Ebetino FH
    Bioorg Med Chem Lett; 2008 Feb; 18(3):1223-8. PubMed ID: 18078748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melanocortin subtype-4 receptor agonists containing a piperazine core with substituted aryl sulfonamides.
    Fotsch C; Han N; Arasasingham P; Bo Y; Carmouche M; Chen N; Davis J; Goldberg MH; Hale C; Hsieh FY; Kelly MG; Liu Q; Norman MH; Smith DM; Stec M; Tamayo N; Xi N; Xu S; Bannon AW; Baumgartner JW
    Bioorg Med Chem Lett; 2005 Mar; 15(6):1623-7. PubMed ID: 15745810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity relationships of piperazinebenzylamines as potent and selective agonists of the human melanocortin-4 receptor.
    Pontillo J; Tran JA; Arellano M; Fleck BA; Huntley R; Marinkovic D; Lanier M; Nelson J; Parker J; Saunders J; Tucci FC; Jiang W; Chen CW; White NS; Foster AC; Chen C
    Bioorg Med Chem Lett; 2004 Sep; 14(17):4417-23. PubMed ID: 15357964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.